title: [Affective disorders and their treatment during pregnancy and after birth -- a review].
abstract: Treatment and management of affective disorders associated with pregnancy is still an underemphasized field receiving little attention, furthermore, it is burdened with misinformation as well as incomplete or missing knowledge. Professionals of related fields (psychiatrists, obstetrician-gynecologists) often provide patients with contradicting information or, due to their lack of sufficient knowledge, keep referring the patient for information between different services. However, there is an increasing amount of data and information available, suitable for drawing conclusions and making it possible to provide adequate and credible counselling and information for pregnant women or family planning couples. In the present paper we aim to facilitate this process by reviewing the currently available information.
authors.affiliation: Zádory Pszichiátriai és Pszichoterápiás Rendelő, Budapest, Hungary. info@zadoryrendelo.hu
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Félegyházy
authors.forename: Mats
authors.initials: M
authors.lastname: Adler
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001942:Breast Feeding; D003376:Counseling; D019052:Depression, Postpartum / Q000188:drug therapy; D004334:Drug Administration Schedule; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D018020:Lithium Compounds / Q000627:therapeutic use; D008875:Middle Aged; D019964:Mood Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D012720:Severity of Illness Index
chemical_list: D000927:Anticonvulsants; D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D017367:Selective Serotonin Reuptake Inhibitors